If your statement states to make checks payable to Cardionet, LLC

Cardionet, LLC
PO BOX 508
Malvern, PA 19355

You can pay online by logging onto https://cardionet.mybalanceonline.com/
Create a One-Time Payment or Secure Online Account.
Call to make payment: 877-837-6027 M-Th 8AM-6PM, Fri 8AM-5PM, Sat 9AM-2PM Eastern Standard Time.

If your statement is payable to GENEVA HEALTHCARE INC.

You can follow the patient payment link below where you can pay with the Papaya App.
For technical support please call 1-619-376-1925.
You can pay online by logging onto https://ppaya.com/pay/payment.php?p=mAD9as9nyM/

    White Paper

    Exploring Immunotherapies: Beyond Checkpoint Inhibitors

    Immunotherapy is an emerging class of cancer treatment, which stimulates the body’s immune system to fight cancer. With the approval of three checkpoint inhibitors (ipilimumab, pembrolizumab and nivolumab) by the FDA in the past five years, immunotherapies are seen as exciting treatments able to elicit durable cures. Download our white paper to discover: Emerging immunotherapeutic […]

    Jun 1, 2016

    White Paper

    Non-invasive Quantification of Fatty Liver Disease

    Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatisis (NASH) are emerging as the most prevalent causes of liver disease in Western countries. There are various methods used to evaluate fat content as well as other characteristics of the liver. Medical imaging provides a non-invasive approach to quantify tissue characteristics of the liver while reducing errors in […]

    Sep 1, 2015

    White Paper

    Immunotherapy – Concept Turned Reality

    While using the body’s own immune system as a therapeutic approach to fight cancer is not a new concept in oncology, recent successes in clinical studies are making immunotherapy a reality, as it exploits the antitumor capabilities of resident immune cells within the body. This white paper provides an overview of the immune system and […]

    Jul 20, 2015

    White Paper

    Blood Pressure Evaluation During Early Phase Trials

    As we know, more attention is being paid to blood pressure (BP) effects in new chemical entities under development for non-hypertension indications, especially when these are not anticipated or thoroughly defined during drug development. Discovering negative results for BP elevation in early trials, would allow more informed planning for BP safety monitoring in later trials. Download […]

    Nov 3, 2014

    White Paper

    ECHO Inter/Intra-Reader Variability

    BioTelemetry Research performed a blinded reading to define the variability between inter-reader and intra-reader assessments. The reading was conducted for 58 ECHO studies by two physicians and 29 ECHOs re-read by the same reader. Download our white paper to discover the findings between inter-reader and intra-reader variability for several ECHO Cardiogram parameters, including: Protocol information ECHO […]

    Sep 4, 2014

    White Paper

    Effect of Anagrelide on Cardiac Repolarization in Healthy Volunteers: A Randomized, Double-Blind, Placebo- and Positive-Controlled, Thorough QT Study

    The assessment of drug-induced changes in the QT and QTc interval has become a necessary component of drug development. This is because of the potential for new drugs with suspected or known effects on the heart to cause life-threatening delayed cardiac repolarization. A study was conducted to evaluate the effects of low and high therapeutic […]

    Aug 3, 2014

    Contact BioTel Research


    Toll-Free: 1.877.267.3324
    Local: 1.301.214.7600
    Fax: 1.301.214.7601

    Local: 1.301.214.7628

    Toll Free: 1.877.324.8326

    USA Offices

    One Preserve Parkway
    Suite 600
    Rockville, MD 20852

    155 Corporate Woods
    Suite 180
    Rochester, NY 14623

    400 Oyster Point Blvd
    Suite 339
    South San Francisco, CA 94080

    International Offices

    Building 3 Chiswick Park
    Suite 258
    566 Chiswick High Road
    London, W4 5YA

    On LinkedIn

    Connect with Us for the latest on our clinical trials services, including medical imaging and cardiac safety testing

    Contact BioTelemetry

    General Inquiries

    Phone: 888.312.BEAT (2328)
    Fax: 610.828.8048

    Investors Information

    Contact: Heather Getz, EVP, CFO & CAO
    Phone: 800.908.7103

    Media Inquiries

    Phone: 800.908.7103